Clinical Trials Browser

Has results × Prostatic Neoplasms × ixabepilone × Clear all

NCT00828308 2022-03-08

Neoadjuvant Weekly Ixabepilone for High Risk, Clinically Localized Prostate Cancer

Phase 2 Completed

16 enrolled 7 charts

Prostatic Neoplasms

NCT00331344 2017-10-31

Treating Patients With Metastatic Prostate Cancer Not Responding to Hormone and Chemotherapy

Phase 1/2 Completed

100 enrolled 10 charts

Prostatic Neoplasms

NCT00087139 2014-05-09

Ixabepilone in Treating Patients With Metastatic Prostate Cancer

Phase 2 Completed

124 enrolled 10 charts

Prostatic Neoplasms